Reason for request
Inclusion
Clinical Benefit
| Insufficient |
The actual benefit of CLIMASTON 0.5 mg/2.5 mg is insufficient for reimbursement by National Health Insurance in the Marketing Authorisation indication. |
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
DEvp4nWR2kJfk3za
Listen
